Chris Murray joined Astex in 2000. He has overall responsibility for the Informatics groups in modelling, chemoinformatics and bioinformatics. At Astex, Chris helped establish Fragment based drug discovery methodologies and has supported the development of computational tools that facilitate drug discovery. Chris has acted as project leader on a number of projects that have delivered clinical candidates and one project that has led to a launched drug. He joined Astex from Protherics, a UK-based biotechnology company, where he headed up the developmental team working on virtual screening docking codes and went on to lead the molecular design group. Dr Murray obtained his degree and doctorate in Chemistry from the University of Cambridge, UK, and subsequently worked as a postdoctoral researcher in Indiana University, Bloomington, USA before beginning his industrial career. He is a co-author on over a hundred publications.